Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
63,812,102
-
Shares change
-
+1,112,846
-
Total reported value, excl. options
-
$1,583,293,444
-
Value change
-
+$44,287,843
-
Put/Call ratio
-
14%
-
Number of buys
-
111
-
Number of sells
-
101
-
Price
-
$24.81
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2016
As of 31 Dec 2016 GLOBUS MEDICAL INC - Class A Stock (GMED) had 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,812,102 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, ABERDEEN ASSET MANAGEMENT PLC/UK, STATE STREET CORP, Van Berkom & Associates Inc., BlackRock Institutional Trust Company, N.A., OAK RIDGE INVESTMENTS LLC, and Consonance Capital Management LP.
This table shows 259 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.